The Bupivacaine Liposome, cataloged under National Stock Number 6505-01-728-5898, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Pacira Pharmaceuticals, Inc. Dba Pacira Pharmaceuticals Inc Div Federal. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-728-5898 |
| Primary Part Number | NDC65250-0266-09 |
| Item Name | Bupivacaine Liposome |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Pacira Pharmaceuticals, Inc. Dba Pacira Pharmaceuticals Inc Div Federal |
| Status | ACTIVE |
| Primary Container Type | VIAL |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC65250-0266-09 PRIMARY | Pacira Pharmaceuticals, Inc. Dba Pacira Pharmaceuticals Inc Div Federal (USA) |
| NDC65250-0266-09 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM251316 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1681967 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-728-5898 is a Bupivacaine Liposome, manufactured by Pacira Pharmaceuticals, Inc. Dba Pacira Pharmaceuticals Inc Div Federal, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-728-5898 has 2 manufacturer part numbers on file: NDC65250-0266-09 (Pacira Pharmaceuticals, Inc. Dba Pacira Pharmaceuticals Inc Div Federal), NDC65250-0266-09 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office).
Key specifications for NDC65250-0266-09: Primary Container Type: VIAL; Special Features: BUPIVACAINE LIPOSOME(PF) 1.3%(13.3 MG/ML) SUSPENSION FOR INFILTRATION 20ML. STORE VIALS REFRIGERATED BETWEEN 2 C TO 8 C (36 F TO 46 F). MAY BE HELD AT A CONTROLLED ROOM TEMPERATURE OF 20 C TO 25 C (68 F TO 77 F) FOR UP TO 30 DAYS IN SEALED, INTACT (UNOPENED) VIALS. DO NOT RE-REFRIGERATE VIALS. DO NOT FREEZE OR EXPOSE TO HIGH TEMPERATURES (GREATER THAN 40 C OR 104 F) FOR AN EXTENDED PERIOD. DO NOT ADMINISTER IF IT IS SUSPECTED OF HAVING BEEN FROZEN OR EXPOSED TO HIGH TEMPERATURES. DO NOT USE THE VIAL IF THE STOPPER IS BULGING.; Part Name Assigned by Controlling Agency: BUPIVACAINE LIPOSOME 1.3% 20ML VIAL 10EA. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.